Bacillus Calmette-Guerin in Immunosuppressed Patient with High-Grade Nonmuscle Invasive Bladder Carcinoma

被引：6

作者：

Aznar Martinez, Laura ^{[1
]}

Lopez Cubillana, Pedro ^{[1
]}

Lopez Abadb, Alicia ^{[2
]}

Vidal Crespo, Natalia ^{[1
]}

Gomez Gomez, Guillermo Antonio ^{[1
]}

机构：

[1] Virgen de la Arrixaca Clin Univ Hosp, Dept Urol, Enrique Gallego 17, ES-30120 Murcia, Spain

[2] Univ Murcia, Dept Urol, Murcia, Spain

来源：

UROLOGIA INTERNATIONALIS | 2019年 / 103卷 / 02期

关键词：

Nonmuscle invasive bladder cancer; Immunosuppressed; Kidney transplant; Treatment; RENAL-TRANSPLANT RECIPIENTS; TRANSITIONAL-CELL CARCINOMA; CANCER;

D O I：

10.1159/000501108

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Due to their immunosuppressed status, solid organ transplant recipients are a special group of patients with an incidence of bladder cancer greater than the rest of the population, especially in the first 6 years after transplantation. Also, treatment with Bacillus Calmette-Guerin, a reference therapy in nonmuscle invasive high-risk bladder cancer, may be less effective in this group of patients and could cause more adverse effects. However, the data published so far and the experience initiated in the Virgen de la Arrixaca Clinical University Hospital do not support these hypotheses. (C) 2019 S. Karger AG, Basel

引用

页码：242 / 244

页数：3